The design of a Social Cost-Benefit Analysis of preventive interventions for toxoplasmosis: An example of the One Health approach.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsSuijkerbuijk, A W M
van Gils, P F
Bonačić Marinović, A A
Feenstra, T L
Kortbeek, L M
Mangen, M-J J
de Wit, G A
van der Giessen, J W B
MetadataShow full item record
TitleThe design of a Social Cost-Benefit Analysis of preventive interventions for toxoplasmosis: An example of the One Health approach.
Published inZoonoses Public Health 2018; 65(1):185-94
PubliekssamenvattingToxoplasma gondii infections cause a large disease burden in the Netherlands, with an estimated health loss of 1,900 Disability Adjusted Life Years and a cost-of-illness estimated at €44 million annually. Infections in humans occur via exposure to oocysts in the environment and after eating undercooked meat containing tissue cysts, leading to asymptomatic or mild symptoms, but potentially leading to the development of ocular toxoplasmosis. Infection in pregnant women can lead to stillbirth and disorders in newborns. At present, prevention is only targeted at pregnant women. Cat vaccination, freezing of meat destined for undercooked consumption and enhancing biosecurity in pig husbandries are possible interventions to prevent toxoplasmosis. As these interventions bear costs for sectors in society that differ from those profiting from the benefits, we perform a social cost-benefit analysis (SCBA). In an SCBA, costs and benefits of societal domains affected by the interventions are identified, making explicit which stakeholder pays and who benefits. Using an epidemiological model, we consider transmission of T. gondii after vaccination of all owned cats or cats at livestock farms. To identify relevant high-risk meat products that will be eaten undercooked, a quantitative microbial risk assessment model developed to attribute predicted T. gondii infections to specific meat products will be used. In addition, we evaluate serological monitoring of pigs at slaughter followed by an audit and tailor made advice for farmers in case positive results were found. The benefits will be modelled stochastically as reduction in DALYs and monetized in Euro's following reference prices for DALYs. If the balance of total costs and benefits is positive, this will lend support to implementation of these preventive interventions at the societal level. Ultimately, the SCBA will provide guidance to policy makers on the most optimal intervention measures to reduce the disease burden of T. gondii in the Netherlands.
- Break-even analysis of costs for controlling Toxoplasma gondii infections in slaughter pigs via a serological surveillance program in the Netherlands.
- Authors: van Asseldonk M, van Wagenberg CPA, Wisselink HJ
- Issue date: 2017 Mar 1
- A computer simulation of the prevention of the transmission of Toxoplasma gondii on swine farms using a feline T. gondii vaccine.
- Authors: Mateus-Pinilla NE, Hannon B, Weigel RM
- Issue date: 2002 Sep 10
- Risk factors for Toxoplasma gondii infection in the United States.
- Authors: Jones JL, Dargelas V, Roberts J, Press C, Remington JS, Montoya JG
- Issue date: 2009 Sep 15
- Vaccination of pigs with the S48 strain of Toxoplasma gondii--safer meat for human consumption.
- Authors: Burrells A, Benavides J, Cantón G, Garcia JL, Bartley PM, Nath M, Thomson J, Chianini F, Innes EA, Katzer F
- Issue date: 2015 May 1
- Intervention strategies to reduce human Toxoplasma gondii disease burden.
- Authors: Opsteegh M, Kortbeek TM, Havelaar AH, van der Giessen JW
- Issue date: 2015 Jan 1